Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children

OBJECTIVES: The LumiraDx SARS-CoV-2 Ag Test has previously been shown to accurately detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals symptomatic for coronavirus disease 2019 (COVID-19). This evaluation investigated the LumiraDx SARS-CoV-2 Ag Test as an aid in the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Drain, Paul, Sulaiman, Raed, Hoppers, Melanie, Lindner, Nigel M, Lawson, Vicki, Ellis, Jayne E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973256/
https://www.ncbi.nlm.nih.gov/pubmed/34668536
http://dx.doi.org/10.1093/ajcp/aqab173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973256/
https://www.ncbi.nlm.nih.gov/pubmed/34668536
http://dx.doi.org/10.1093/ajcp/aqab173

Ejemplares similares